SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-20-002367
Filing Date
2020-06-11
Accepted
2020-06-11 11:43:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 THERAVANCE BIOPHARMA, INC. p20-1227sc13g.htm SC 13G 50294
  Complete submission text file 0000902664-20-002367.txt   51877
Mailing Address 4 PARK PLAZA SUITE 550 IRVINE CA 92614
Business Address 4 PARK PLAZA SUITE 550 IRVINE CA 92614 9494808300
ACACIA RESEARCH CORP (Filed by) CIK: 0000934549 (see all company filings)

IRS No.: 954405754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6794 Patent Owners & Lessors

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 20956621
SIC: 2834 Pharmaceutical Preparations